Verrica Pharmaceuticals (VRCA) EPS (Basic) (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly EPS (Basic) of -$0.49 for Q1 2026, up 53.04% year-over-year from -$0.32 in Q1 2025, and up 49.19% quarter-over-quarter from -$0.97 in Q4 2025.
Verrica Pharmaceuticals (VRCA) EPS (Basic) (2017 - 2026) Analysis & Trends
Verrica Pharmaceuticals' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$0.49 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 53.04% year-over-year to -$0.49; the TTM figure through Mar 2026 stood at -$1.16 (up 84.46% YoY), while the FY2025 annual figure was -$7.98, up 69.47% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.49, up from -$0.97 in the prior quarter.
- The five-year high for EPS (Basic) was $0.02 in Q2 2025, with the low at -$582.34 in Q1 2024.
- The 5-year median for EPS (Basic) is -$2.5 (2024), against an average of -$36.61.
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) tumbled 26240.35% in 2023, then surged 100.58% in 2025.
- Verrica Pharmaceuticals' EPS (Basic) stood at -$1.85 in 2022, then tumbled by 188.73% to -$5.33 in 2023, then surged by 53.16% to -$2.5 in 2024, then soared by 61.0% to -$0.97 in 2025, then soared by 49.19% to -$0.49 in 2026.
- Business Quant data shows VRCA's EPS (Basic) at -$0.49 in Q1 2026, -$0.97 in Q4 2025, and -$0.43 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Verrica Pharmaceuticals | 104.71 Mn | 93.51 Mn | - | -0.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.68 |
| Mar 31, 2026 | -0.49 |
| Dec 31, 2025 | -0.97 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | -1.05 |
| Dec 31, 2024 | -2.50 |
| Sep 30, 2024 | -6.61 |
| Jun 30, 2024 | -3.70 |
| Mar 31, 2024 | -582.34 |
| Dec 31, 2023 | -5.33 |
| Sep 30, 2023 | -5.38 |
| Jun 30, 2023 | -2.39 |
| Mar 31, 2023 | -2.53 |
| Dec 31, 2022 | -1.85 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | -3.81 |
| Mar 31, 2022 | -3.08 |
| Dec 31, 2021 | -3.93 |
| Sep 30, 2021 | -4.67 |